Nosocomial infection after lung surgery: Incidence and risk factors

Chest

Volumn 128, Issue 4, 2005, Pages 2647-2652

  Nan, Daniel N ^a   Fernández Ayala, Marta ^a   Fariñas Álvarez, Concepción ^a   Mons, Roberto ^a   Ortega, Francisco J ^a   González Macías, Jesús ^a   Fariñas, M Carmen ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Lung resection; Nosocomial infection; Risk factors; Thoracic surgery

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME;

ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THORAX SURGERY; WOUND INFECTION;

EID: 27144520223     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.4.2647     Document Type: Article

References (25)

1. Wada H, Nakamura T, Nakamoto K, et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998; 115:70-73
2. Turna A, Kutlu CA, Ozalp T, et al. Antibiotic prophylaxis in elective thoracic surgery: cefuroxime versus cefepime. Thorac Cardiovasc Surg 2003; 51:84-88
3. Cameron JL, Imbembo A, Kieffer RF, et al. Prospective clinical trial of antibiotics for pulmonary resections. Surg Gynecol Obstet 1981; 152:156-158
4. Bernard A, Fillet M, Goudet P, et al. Antibiotic prophylaxis in pulmonary surgery: a prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J Thorac Cardiovasc Surg 1994; 107:896-900
5. Stéphan F, Boucheseiche S, Hollande J, et al. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest 2000; 118:1263-1270
6. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: a prospective multicenter study. Ann Thorac Surg 1997; 63:944-950
7. Boldt J, Piper S, Uphus D, et al. Preoperative microbiologic screening and antibiotic prophylaxis in pulmonary resection operations. Ann Thorac Surg 1999; 68:208-211
8. Lopez Pujol J, Alvarez Kindelan A, Algar J, et al. Perioperative morbimortality in pneumonectomy: analysis of risk factors [in Spanish] Arch Bronconeumol 2000; 36:251-256
9. Kluytmans JA, Mounton JW, Maat AP, et al. Surveillance of postoperative infections in thoracic surgery. J Hosp Infect 1994; 27:139-147
10. Olak J, Jeyasingham K, Forrester-Wood C, et al. Randomized trial of one-dose versus six-dose cefazolin prophylaxis in elective general thoracic surgery. Ann Thorac Surg 1991; 51:956-958
11. Tarka M, Pokela R, Lepojarvi M, et al. Infection prophylaxis in pulmonary surgery: a randomized prospective study. Ann Thorac Surg 1987; 44:508-513
12. Reimer K, Gleed C, Nicolle LE. The impact of postdischarge infection on surgical wound infection rates. Infect Control 1987; 8:237-240
13. Manian FA, Meyer L. Comprehensive surveillance of surgical wound infections in outpatient and inpatient surgery. Infect Control Hosp Epidemiol 1990; 11:515-520
14. Kollef MH, Sharpless L, Vlasnik J, et al. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997; 112:666-675
15. Owens W, Felts J, Spitznagel E. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978; 49:239-243
16. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140
17. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-608
18. Deschamps C, Bernad A, Nichols FC 3rd, et al. Empyema and bronchopleural fistula after pneumonectomy factors affecting incidence. Ann Thorac Surg 2001; 72:243-247
19. Ferdinand B, Shennib H. Postoperative pneumonia. Chest Surg Clin N Am 1998; 8:529-539
20. Wahi R, McMurtey MJ, DeCaro LF, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg 1989; 48:33-37
21. Moliterno AR, Spivak JL. Anemia of cancer. Hematol Oncol Clin North Am 1996; 10:345-363
22. Garibaldi RA, Cushing D, Lerer T. Risk factors for postoperative infection. Am J Med 1991; 91(suppl 3B):158S-163S
23. Breyer RH, Zippe C, Pharr WF, et al. Thoracotomy in patients over age seventy years: ten-year experience. J Thorac Cardiovasc Surg 1981; 81:187-193
24. Fariñas MC, Galo Peralta F, Bernal JM, et al. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995; 20:272-279
25. Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 2002; 121: 1890-1897